The calcium/phosphorus homeostasis in chronic kidney disease: From clinical epidemiology to pathophysiology

• Autor(a) principal: Pires, A.
• Data de Publicação: 2017
• Outros Autores: Sobrinho, L., Ferreira, H.G.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.20344/amp.8040
• topic: Calcium; Chronic; Homeostasis; Hyperparathyroidism; Kidney Failure; Phosphorus

Export Date: 19 October 2017 CODEN: AMPOD Correspondence Address: Pires, A.; Serviço de Nefrologia, Hospital Fernando da FonsecaPortugal; email: [e-mail] References: Pires, A., Adragao, T., Pais, M.J., Vinhas, J., Ferreira, H.G., Inferring disease mechanisms from epidemiological data in chronic kidney disease: Calcium and phosphorus metabolism (2009) Nephron Clin Pract, 112, pp. c137-c147; Manjunath, G., Sarnak, M.J., Levey, A.S., Prediction equations to estimate glomerular filtration rate: An update (2001) Curr Opin Nephrol Hypertens, 10, pp. 785-792; Cannata-Andía, J.B., Martin, K.J., The challenge of controlling phosphorus in chronic kidney disease (2016) Nephrol Dial Transplant, 31, pp. 541-547; Ben-Dov, I.Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro, M., Mohammadi, M., The parathyroid is a target organ for FGF-23 in rats (2007) J Clin Invest, 117, pp. 4003-4008; Brown, E.M., Juppner, H., Parathyroid hormone: Synthesis, secretion and action (2006) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, pp. 90-99. , Favus MJ, editor, 6th ed. Washington: American Society for Bone and Mineral Research; Felsenfeld, A.J., Levine, B.S., Rodriguez, M., Pathophysiology of calcium, phosphorus and magnesium dysregulation in chronic kidney disease (2015) Semin Dial, 28, pp. 564-577; Habener, J.F., Rosenblatt, M., Potts, J.T., Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action and metabolism (1984) Physiol Rev, 64, pp. 985-1053; Brown, E.M., Four parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular Ca concentration in normal and abnormal parathyroid tissue (1983) J Clin Endocrinol Metab, 56, pp. 572-581; Milsum, J.H., (1966) Biological Control Systems Analysis, , Columbus: McGraw-Hill Inc; Guyton, A.C., Jones, C.E., Coleman, T.G., (1973) Circulatory Physiology: Cardiac Output and Its Regulation, , Philadelphia: WB Saunders Co; Spiegel, M.R., Stephens, L.J., (1961) Schaum’s Outline of Statistics, pp. 436-437. , 3rd ed. Columbus: McGraw-Hill Inc; K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification (2002) Am J Kidney Dis, 39, p. S1; Parfitt, A.M., Calcium homeostasis (1993) Physiology and Pharmacology of Bone, pp. 1-66. , Mundy GR, Martin TJ, editors, Berlin: Springer-Verlag; Bergwitz, C., Jüppner, H., Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23 (2010) Annu Rev Med, 61, pp. 91-104; Berndt, T., Kumar, R., Clinical disturbances of phosphate homeostasis (2008) Seldin and Giebisch´s the Kidney Physiology and Pathology, pp. 1989-2006. , Alpern R, Hebert S, editors, 4th ed. Amsterdam: Elsevier; Mundy, G.R., Hormonal factors which regulate bone (1993) Physiology and Pharmacology of Bone, pp. 215-248. , Mundy GR, Martin TJ, editors, Berlin: Springer-Verlag; Tatsumi, S., Miyagawa, A., Kaneko, I., Shiozaki, Y., Segawa, H., Miyamoto, K., Regulation of renal phosphate handling: Inter-organ communication in health and disease (2016) J Bone Miner Metab, 34, pp. 1-10; Blaine, J., Chonchol, M., Levi, M., Renal control of calcium, phosphate, and magnesium homeostasis (2015) Clin J am Soc Nephrol, 10, pp. 1257-1272; Drüeke, T.B., Massy, Z.A., Changing bone patterns with progression of chronic kidney disease (2016) Kidney Int, 89, pp. 289-302; Ritter, C.S., Slatopolsky, E., Phosphate toxicity in CKD: The killer among Us (2016) Clin J am Soc Nephrol, 11, pp. 1088-1100; Al-Aly, Z., Qazi, R.A., González, E.A., Zeringue, A., Martin, K.J., Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD (2007) Am J Kidney Dis, 50, pp. 59-68; Kandula, P., Dobre, M., Schold, J.D., Schreiber, M.J., Jr., Mehrotra, R., Navaneethan, S.D., Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials (2011) Clin J am Soc Nephrol, 6, pp. 50-62; Slatopolsky, E., Lopez-Hilker, S., Delmez, J., Dusso, A., Brown, A., Martin, K.J., The parathyroid-calcitriol axis in health and chronic renal failure (1990) Kidney Int Suppl, 29, pp. S41-S47; Koenig, K.G., Lindberg, J.S., Zerwekh, J.E., Padalino, P.K., Cushner, H.M., Copley, J.B., Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease (1992) Kidney Int, 4, pp. 161-165; Prince, R.L., Hutchison, B.G., Kent, J.C., Kent, G.N., Retallack, R.W., Calcitriol deficiency with retained synthetic reserve in chronic renal failure (1988) Kidney Int, 33, pp. 722-728; Malluche, H.H., Werner, E., Ritz, E., Intestinal absorption of calcium and whole-body calcium retention in incipient and advanced renal failure (1978) Miner Electrolyte Metab, 1, pp. 263-270; St-Arnaud, R., Demay, M.B., Vitamin D biology (2003) Pediatric Bone: Biology and Diseases, pp. 193-216. , Glorieux FH, Pettifor JM, Juppner H, editors, San Diego: Academic Press; Llach, F., Massry, S.G., On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency (1985) J Clin Endocrinol Metab, 61, pp. 601-606; Delmez, J.A., Slatopolsky, E., Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease (1992) Am J Kidney Dis, 19, pp. 303-317; Isakova, T., Wahl, P., Vargas, G.S., Gutiérrez, O.M., Scialla, J., Xie, H., Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease (2011) Kidney Int, 79, pp. 1370-1378; Evenepoel, P., Meijers, B., Viaene, L., Bammens, B., Claes, K., Kuypers, D., Fibroblast growth factor-23 in early chronic kidney disease: Additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism (2010) Clin J am Soc Nephrol, 5; Vervloet, M.G., Massy, Z.A., Brandenburg, V.M., Mazzaferro, S., Cozzolino, M., Ureña-Torres, P., Bone: A new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders (2014) Lancet Diabetes Endocrinol, 2, pp. 427-436; Gutiérrez, O.M., Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the “trade-off” hypothesis (2010) Clin J am Soc Nephrol, 5, pp. 1710-1716; Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease (2005) J am Soc Nephrol, 16, pp. 2205-2215; Slatopolsky, E., Delmez, J.A., Pathogenesis of secondary hyperparathyroidism (1996) Nephrol Dial Transplant, 11, pp. 130-135; Craver, L., Marco, M.P., Martínez, I., Rue, M., Borràs, M., Martín, M.L., Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges (2007) Nephrol Dial Transplant, 22, pp. 1171-1176; Evenepoel, P., Rodriguez, M., Ketteler, M., Laboratory abnormalities in CKD-MBD: Markers, predictors, or mediators of disease? (2014) Semin Nephrol, 34, pp. 151-163; Bellasi, A., Pro: Should phosphate binders be used in chronic kidney disease stage 3-4? (2016) Nephrol Dial Transplant, 31, pp. 184-188; Dusso, A., González, E.A., Martin, K.J., Vitamin D in chronic kidney disease (2011) Best Pract Res Clin Endocrinol Metab, 25, pp. 647-655; Quarles, L.D., Role of FGF-23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease (2012) Exp Cell Res, 318, pp. 1040-1048; Brown, A., Dusso, A., Slatopolsky, E., Vitamin, D., (2008) Seldin and Giebisch´s the Kidney Physiology and Pathology, pp. 1803-1849. , Alpern R, Hebert S, editors, 4th ed. Amsterdam: Elsevier; Fraser, W.D., Hyperparathyroidism (2009) Lancet, 374, pp. 145-158; Dhayat, N.A., Ackermann, D., Pruijm, M., Ponte, B., Ehret, G., Guessous, I., Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function (2016) Kidney Int, 90, pp. 648-657; Wolf, M., Mineral (Mal)adaptation to kidney disease (2015) Clin J am Soc Nephrol, 10, pp. 1875-1885; Levin, A., Bakris, G.L., Molitch, M., Smulders, M., Tian, J., Williams, L.A., Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease (2007) Kidney Int, 71, pp. 31-38; Perwad, F., Zhang, M.Y., Tenenhouse, H.S., Portale, A.A., Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro (2007) Am J Physiol Renal Physiol, 293, pp. F1577-F1583; Liu, S., Quarles, L.D., How FGF-23 works (2007) J am Soc Nephrol, 18, pp. 1637-1647; Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis (2004) Bone Miner Res, 19, pp. 429-435; Erben, R.G., Andrukhova, O., FGF23-Klotho signaling axis in the kidney (2017) Bone; Ix, J.H., Shlipak, M.G., Wassel, C.L., Whooley, M.A., Fibroblast growth factor-23 and early decrements in kidney function: The heart and soul Study (2010) Nephrol Dial Transplant, 25, pp. 993-997; Kovesdy, C.P., Quarles, L.D., FGF23 from bench to bedside (2016) Am J Physiol Renal, 310, pp. F1168-F1174; Kuro, M., Moe, O.W., FGF23-αKlotho as a paradigm for a kidney-bone network (2017) Bone